FindTrial
Sign In

Colonscopic adiministration of probiotics for irritable bowel syndrome with predominant diarrhea

A prospective trial of colonscopic adiministration of probiotics for irritable bowel syndrome with predominant diarrhea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010411
Enrollment
Unknown
Registered
2017-01-13
Start date
2017-02-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome with predominant diarrhea

Interventions

test group:Colonscopic adiministration of probiotics
control group:Colonscopic adiministration of normal saline

Sponsors

Department of Endoscopy, The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with clinical diagnosis of irritable bowel syndrome with predominant diarrhea according to the clinical diagnosis and treatment guidelines of Rome IV criteria.

Exclusion criteria

Exclusion criteria: Patients with weakness physical condition which could not tolerate or reject bowel preparation and colonscopy examination, with the presence of other bowel diseases,with pregnancy, age less than 14 years,and currently particpator of other clinic trial,drug history of antibiotics and microecologics within last 3 months or gastrointestinal excitomotor within last 3 weeks.In addition,the other cases are not fit for this study under investigators' consideration.

Design outcomes

Primary

MeasureTime frame
abdominal pain;constipation;fecal bacteria;quality of life;—

Countries

China

Contacts

Public ContactZe-Hao Zhuang

Department of Endoscopy, The First Affiliated Hospital of Fujian Medical University

zhuang203@yeah.net+86 13178032412

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026